[Present-day problems of clinical pharmacogenetics].
The authors deal with the problem of clinical introduction of pharmacogenetic studies to individualize pharmacotherapy. On the basis of their own studies they propose the methodology of studying the clinical significance of pharmacogenetic studies of biotransformation system and drug transporters, and formulate the main requirements pharmacogenetic studies should meet to be introduced to clinical practice.